AIM ImmunoTech Inc
AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.
What If You Bought AIM Earlier?
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Feb 10, 2026 | $0.97 | 1031-for-1000 | 1.031× | 1.0320309999999997× |
| Jan 9, 2026 | — | 1001-for-1000 | 1.001× | 1.001× |
AIM ImmunoTech Inc Market Cap Timeline
Market capitalization from public listing to today. Split markers cover all 2 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.